Cell Bio Human Tech셀바이오휴먼텍
318160 · KOSDAQ · ₩318160 · 셀바이오휴먼텍
- Market cap
- ₩57B
- Enterprise value
- ₩66B
- P/E
- 5.4×
- P/B
- 0.9×
- Dividend yield
- 0.0%
- ROE
- 17.2%
- Net margin
- 17.3%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−44.8% from the high
₩4,960Today: ₩5,950 – ₩6,220₩11,060
Returns
- 1W−3.9%
- 1M−12.6%
- 3M+4.3%
- 6M−20.3%
- YTD−25.3%
- 1Y−40.8%
- Volume today
- 22,165
- 1.4× the 20-day average
- Traded today
- ₩134M
- Listed shares
- 9,392,953
- EPS (12 months)
- ₩1,125
- Earnings yield 18.4%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Normal- BuzzNormalBuzz 48 of 100 (50 is a normal day for this stock).
- MomentumWeak-13.1% over the last month; the price is below its 20-day average.
- News impactSome2 news items and filings in two weeks; 0 rated high impact, 1 medium.
Signals describe activity, not recommendations. Not financial advice.
Cell Bio Human Tech stock overview
Cell Bio Human Tech (셀바이오휴먼텍, KRX: 318160) is listed on KOSDAQ, in the Textiles & Apparel sector. CELLBIO HUMAN TECH is a Korean company founded in 2015 that develops and manufactures eco-friendly mask pack sheet materials using cellulose molecular control technology, supplying domestic and global mask pack brands. Its shares closed at ₩6,100 on Oct 30, 2026, down 2.40% on the day, giving it a market value of ₩57B.
Key facts
- Market cap
- ₩57B
- Sector
- Textiles & Apparel
- Latest price change
- −2.40%
- As of
- Oct 30, 2026
- Main business
- CELLBIO HUMAN TECH is a Korean company founded in 2015 that develops and manufactures eco-friendly mask pack sheet materials using cellulose molecular control technology, supplying domestic and global mask pack brands.
Quick answers about Cell Bio Human Tech
- What does Cell Bio Human Tech do?
- CELLBIO HUMAN TECH is a Korean company founded in 2015 that develops and manufactures eco-friendly mask pack sheet materials using cellulose molecular control technology, supplying domestic and global mask pack brands. It also produces hydrocolloid patch products and, since 2025, offers cosmetic OEM manufacturing of sheet masks, pads, and hydrogel mask packs. The company operates from a factory in Hwaseong Bio Valley Industrial Complex and a non-woven fabric subsidiary in Da Nang, Vietnam.
- What is the market cap of Cell Bio Human Tech?
- The market capitalisation of Cell Bio Human Tech was ₩57B at the close on Oct 30, 2026.
- Who are the largest shareholders of Cell Bio Human Tech?
- According to the latest official filings, the largest reported holders are Lee Gwon-seon (37.13%, as of Jun 12, 2026); Cha Dong-gyun (0.87%, as of Jan 5, 2026); Kwon Seong-won (0.22%, as of Jan 5, 2026).
- When is the next earnings report from Cell Bio Human Tech?
- Korean companies rarely announce results dates in advance. Based on when Cell Bio Human Tech filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
Company profile
CELLBIO HUMAN TECH is a Korean company founded in 2015 that develops and manufactures eco-friendly mask pack sheet materials using cellulose molecular control technology, supplying domestic and global mask pack brands. It also produces hydrocolloid patch products and, since 2025, offers cosmetic OEM manufacturing of sheet masks, pads, and hydrogel mask packs. The company operates from a factory in Hwaseong Bio Valley Industrial Complex and a non-woven fabric subsidiary in Da Nang, Vietnam.
Written by AI from the company's latest annual report.
- Korean name
- 셀바이오휴먼텍
- Sector
- Textiles & Apparel
- Themes
- K-beauty
- CEO
- 이권선
- Founded
- Jul 2015
- Listed
- Apr 2023
- Listed shares
- 9,392,953
- Fiscal year ends
- Month 12
- Website
- cellbiohumantech.co.kr/
Similar companies
- F&F383220 · ₩2.4T₩62,600+2.12%
- LF093050 · ₩646B₩22,100+2.31%
- Chokwang Leather004700 · ₩436B₩65,500+2.99%
- Handsome020000 · ₩400B₩18,630−0.48%
- JS194370 · ₩328B₩11,290−4.00%
- Hansae105630 · ₩327B₩8,180−0.37%
- Ilshin Spinning003200 · ₩238B₩10,360−0.48%
- BYC001460 · ₩215B₩34,400−3.37%
Recent filings
See all- Trust Contract Termination Result ReportOct 21, 2026
- Material Matters Report (Decision on Termination of Trust Agreement for Own Share Acquisition)Oct 21, 2026
- Status Report on Acquisition Under Trust AgreementSep 11, 2026
- Investor relations (IR) eventAug 20, 2026
- Half-year report (Jun 2026)Aug 14, 2026
Titles in Korean until English translations are added.
Also known as: Cell Bio Human Tech / 셀바이오휴먼텍 / 318160 / KRX:318160
Source: KRX statistical information